Literature DB >> 7508844

[The incidences of benign prostatic hyperplasia and prostatic cancer in China].

F L Gu1.   

Abstract

Step-sections of 321 prostatic specimens from unselected autopsies were examined in order to understand the incidences of benign prostatic hyperplasia (BPH) and prostatic cancer (CaP) in China. The results showed that the incidence of BPH in patients of 51-60, 61-70, 71-80, and 81-90 years old was 20%, 50%, 57.1% and 33.3% respectively. The incidence of latent CaP in the above-mentioned age series, including 60 prostatic specimens from cystoprostatectomies was 9.3%, 5.7%, 26.9% and 16.7% respectively. The Incidence of CaP in BPH surgical specimens was 33/676 (4.9%). The histological incidences of BPH and CaP in China were similar to or half of that of western world. But the epidemiological incidence of CaP in China was only 1/20-1/30. Further investigation about this condition is necessary.

Entities:  

Mesh:

Year:  1993        PMID: 7508844

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  3 in total

1.  Oncological and functional results of extraperitoneal laparoscopic radical prostatectomy.

Authors:  Tao Zheng; Xu Zhang; Xin Ma; Hong-Zhao Li; Jiang-Pin Gao; Wei Cai; Guang-Fu Chen; Jun Dong; Bao-Jun Wang; Tao-Ping Shi
Journal:  Oncol Lett       Date:  2012-05-30       Impact factor: 2.967

2.  Efficacy of low-dose tamsulosin in chinese patients with symptomatic benign prostatic hyperplasia.

Authors:  Ning-Chen Li; Shan Chen; Xue-Hui Yang; Lin-Dong Du; Jian-Ye Wang; Yan-Qun Na
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

3.  Effects of Kangquan Recipe on sex steroids and cell proliferation in rats with benign prostatic hyperplasia.

Authors:  Yuan-peng Huang; Jian Du; Zhen-feng Hong; Zhi-qing Chen; Jin-fa Wu; Jin-yan Zhao
Journal:  Chin J Integr Med       Date:  2009-08-18       Impact factor: 1.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.